Front Neurol. 2019 Nov 15;10:1173. doi: 10.3389/fneur.2019.01173. eCollection 2019.
3
Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).